ANGIMET MR 35 mg is a cardioprotective agent containing Trimetazidine, which improves myocardial glucose utilization through inhibition of fatty acid metabolism. It is primarily used in the management of stable angina pectoris, helping to reduce the frequency of angina attacks and improve exercise tolerance without affecting heart rate or blood pressure. The modified-release formulation ensures sustained activity throughout the day.